MASSMUTUAL TRUST CO FSB/ADV - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$1,609
+0.9%
183
+31.7%
0.00%
Q3 2023$1,594
-44.7%
139
+21.9%
0.00%
Q2 2023$2,885
-21.4%
1140.0%0.00%
Q1 2023$3,672
+183500.0%
1140.0%0.00%
Q4 2022$2
-99.9%
114
-11.6%
0.00%
Q3 2022$3,000
+200.0%
129
+258.3%
0.00%
Q4 2021$1,000360.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders